Prakiraan rega marang bathi: CytoSorbents Corporation (CTSO)
Military clashes are driving demand for blood purification in field hospitals, although sanctions complicate logistics. The forward P/E metric for Cytosorbents (CTSO) clearly confirms these trends, with the ratio currently reaching 0.00. Patent protection of the cytokine sorption niche, combined with high cartridge margins, creates powerful operating leverage for profit growth at Cytosorbents.
Rincian metrik lan analitis perusahaan CytoSorbents Corp. (CTSO)
- kuotasi lan prakiraan analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal Cytosorbents|CTSO - Rasio utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Cytosorbents|CTSO - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku CytoSorbents Corp|CTSO - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Cytosorbents|Rasio cepet cytosorbents.com
- rincian asil keuangan lan kelipatan valuasi:
CTSO - Bathi perusahaan|Proyeksi bathi mangsa ngarep Cytosorbents|CTSO - Periode bali modal bisnis|Pangali Forward P/E Cytosorbents|CTSO - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA CytoSorbents Corp|CTSO - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Cytosorbents|CTSO - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan cytosorbents.com|CTSO - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Cytosorbents
Pambiji fundamental:CTSO CytoSorbents Corporation
High margins in the production of sorption cartridges and the operating leverage effect from scaling within intensive care units create a foundation for the rapid profit growth of Cytosorbents (CTSO). The company's expected P/E ratio quantifies this potential by comparing market capitalization with projected earnings, allowing investors to assess the premium paid for future growth and determine the risk of correction through the price action of this chart.
Pesaing Cytosorbents
Pangali Forward P/E DXCM|PEN - Rasio prakiraan rega marang bathi|Novanta Corp - Prakiraan rega marang bathi|Pangali Forward P/E Haemonetics Company HAE|INSP: Prakiraan rega marang bathi|procept-biorobotics.com - Rasio kapitalisasi marang bathi mangsa ngarep|CNMD: Pangali Forward P/E|PLSE - Kapitalisasi marang proyeksi bathi|INMD (InMode Corp) - Pangali Forward P/E|Prakiraan rega marang bathi Picard Group (PMI)|Prakiraan rega marang bathi SRDX (Surmodics, Inc.)|SENS (Senseonics Holdings, Inc.) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep NeuroPace NPCE|TCMD - Prakiraan rega marang bathi|SANUWAVE Health, Inc. - Pangali Forward P/E|Rasio prakiraan rega marang bathi Outset Medical Corp|ELMD: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep LNSR|RCEL (AVITA Medical) - Pangali Forward P/E|Profound Medical Corporation (PROF) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E BDMD|Prakiraan rega marang bathi edap-tms.com EDAP|Pangali Forward P/E APYX (Apyx Medical Corporation)|Pangali Forward P/E IceCure Medical Ltd. ICCM|LUNG - Rega marang bathi mangsa ngarep|TELA: Rega marang bathi mangsa ngarep|SRTS (Sensus Healthcare Corp) - Prakiraan rega marang bathi|Zynex Corp - Pangali mangsa ngarep rega marang bathi|ECOR (electroCore Inc) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Vicarious Surgical Corp RBOT|Rega marang bathi mangsa ngarep Inspira Technologies Oxy (IINN)|SeaStar Medical Holding Corporation (ICU) - Pangali forward rega marang bathi|IRIDEX - Prakiraan rega marang bathi|Pangali Forward P/E Intelligent Bio Solutions Inc INBS|AINostix - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi profusa.com PFSA|strataskinsciences.com (SSKN) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake GCTK (glucotrack.com)|Rega marang bathi mangsa ngarep NanoVibronix|Prakiraan rega marang bathi Venus Concept Corporation (VERO)|Pangali Forward P/E NUWE|AEMD - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Asensus Surgical ASXC|AVGR: Rasio rega marang bathi mangsa ngarep|BSGM: Prakiraan rega marang bathi|Cutera Inc - Rasio kapitalisasi marang bathi mangsa ngarep|KNW: Pangali Forward P/E|Prakiraan rega marang bathi inarimedical.com|Prakiraan rega marang bathi NVRO|Rasio prakiraan rega marang bathi ReShape Lifesciences Inc RSLS|Prakiraan rega marang bathi SILK (Silk Road Medical Inc.)
